[1] Nakamura A, Iguchi H, Takayama M, et al.  Metastatic carcinoma of the neck from unknown primary sites[J]. Nihon Jibiinkoka Gakkai Kaiho, 2003, 106(6): 671-677.   doi: 10.3950/jibiinkoka.106.671
[2] 李嘉旭, 许璐, 李梦丹, 等.  18F-FDG PET/CT全身显像对原发不明转移瘤患者原发灶检出价值的Meta分析[J]. 第三军医大学学报, 2020, 42(13): 1360-1369.   doi: 10.16016/j.1000-5404.202002104
Li JX, Xu L, Li MD, et al.  Diagnostic value of whole body 18F-FDG PET/CT imaging in metastatic cancer of unknown primary: a Meta-analysis[J]. J Third Mil Med Univ, 2020, 42(13): 1360-1369.   doi: 10.16016/j.1000-5404.202002104
[3]

Rudmik L, Lau HY, Matthews TW, et al. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial[J]. Head Neck, 201l, 33(7): 935−940. DOI: 10.1002/hed.21566.
[4] Deron PB, Bonte KM, Vermeersch HF, et al.  Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography[J]. Cancer Biother Radiopharm, 2011, 26(3): 331-334.   doi: 10.1089/cbr.2010.0918
[5] Chen WQ, Zheng RS, Zuo TT, et al.  National cancer incidence and mortality in China, 2012[J]. Chin J Cancer Res, 2016, 28(1): 1-11.   doi: 10.3978/j.issn.1000-9604.2016.02.08
[6] Chen WQ, Zheng RS, Zhang SW, et al.  Cancer incidence and mortality in China, 2013[J]. Cancer Lett, 2017, 401: 63-71.   doi: 10.1016/j.canlet.2017.04.024
[7] Chen WQ, Sun KX, Zheng RS, et al.  Cancer incidence and mortality in China, 2014[J]. Chin J Cancer Res, 2018, 30(1): 1-12.   doi: 10.21147/j.issn.1000-9604.2018.01.01
[8] 郑荣寿, 顾秀瑛, 李雪婷, 等.  2000−2014年中国肿瘤登记地区癌症发病趋势及年龄变化分析[J]. 中华预防医学杂志, 2018, 52(6): 593-600.   doi: 10.3760/cma.j.issn.0253-9624.2018.06.007
Zheng RS, Gu XY, Li XT, et al.  Analysis on the trend of cancer incidence and age change in cancer registry areas of China, 2000 to 2014[J]. Chin J Prev Med, 2018, 52(6): 593-600.   doi: 10.3760/cma.j.issn.0253-9624.2018.06.007
[9] 温树信, 张庆丰, 王鑫, 等.  原发灶不明的颈部淋巴结转移癌诊治策略[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(11): 1014-1016.   doi: 10.13201/j.issn.1001-1781.2019.11.002
Wen SX, Zhang QF, Wang X, et al.  The scheme of diagnosis and treatment on metastatic cervical carcinomas from an unknown primary[J]. J Clin Otorhinolaryngol Head Neck Surg (China), 2019, 33(11): 1014-1016.   doi: 10.13201/j.issn.1001-1781.2019.11.002
[10] Kazmierczak PM, Nikolaou K, Rominger A, et al.  Radiological diagnostics in CUP syndrome[J]. Radiologe, 2014, 54(2): 117-123.   doi: 10.1007/s00117-013-2547-9
[11] AAssar OS, Fischbein NJ, Caputo GR, et al.  Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors[J]. Radiology, 1999, 210(1): 177-181.   doi: 10.1148/radiology.210.1.r99ja48177
[12] Wei KR, Zheng RS, Zhang SW, et al.  Nasopharyngeal carcinoma incidence and mortality in China, 2013[J]. Chin J Cancer, 2017, 36(1): 90-.   doi: 10.1186/s40880-017-0257-9
[13] Al-Brahim N, Ross C, Carter B, et al.  The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center[J]. Ann Diagn Pathol, 2005, 9(2): 77-80.   doi: 10.1016/j.anndiagpath.2004.12.003
[14]

王文萍. 实用肿瘤转移学[M]. 沈阳: 辽宁科学技术出版社, 2003: 20.

Wang WP. Practical oncology metastasis[M]. Shenyang: Liaoning Science and Technology Publishing House, 2003: 20.
[15] 王成锋, 赵平.  应重视不明原发灶肿瘤的临床研究[J]. 中华医学杂志, 2006, 86(26): 1801-1803.   doi: 10.3760/j:issn:0376-2491.2006.26.001
Wang CF, Zhao P.  Clinical research of cancers of unknown primary deserves special emphasis[J]. Natl Med J China, 2006, 86(26): 1801-1803.   doi: 10.3760/j:issn:0376-2491.2006.26.001
[16] 刘方颖, 王全师, 裴著果.  非小细胞肺癌18F-FDG PET显像与增殖细胞核抗原表达的关系[J]. 中华核医学杂志, 2003, 23(1): 14-16.   doi: 10.3760/cma.j.issn.2095-2848.2003.01.004
Liu FY, Wang QS, Pei ZG.  18F-FDG uptake in PET imaging correlates with the proliferating cell nuclear antigen in non-small cell lung cancer[J]. Chin J Uncl Med, 2003, 23(1): 14-16.   doi: 10.3760/cma.j.issn.2095-2848.2003.01.004
[17] 殷玉林, 唐平章, 徐国镇, 等.  颈部原发不明转移癌的治疗与转归[J]. 中华肿瘤杂志, 1999, 21(3): 230-232.   doi: 10.3760/j.issn:0253-3766.1999.03.021
Yin YL, Tang PZ, Xu GZ, et al.  Treatment and outcome of cervical lymph nodal metastases of unknown primary sites[J]. Chin J Oncol, 1999, 21(3): 230-232.   doi: 10.3760/j.issn:0253-3766.1999.03.021
[18] 徐晓辉, 何涛, 王欢.  18F-FDG PET/CT在胃癌术后复发及转移监测中的应用[J]. 中国CT和MRI杂志, 2021, 19(10): 152-154.   doi: 10.3969/j.issn.1672-5131.2021.10.049
Xu XH, He T, Wang H.  Application of 18F-FDG PET/CT in monitoring of recurrence and metastasis after gastric cancer surgery[J]. Chin J CT MRI, 2021, 19(10): 152-154.   doi: 10.3969/j.issn.1672-5131.2021.10.049
[19] Zhao L, Chen SY, Chen SJ, et al.  68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer[J]. Radiother Oncol, 2021, 158: 55-61.   doi: 10.1016/j.radonc.2021.02.015
[20] Hicks RJ, Roselt PJ, Kallur KG, et al.  FAPI PET/CT: will it end the hegemony of 18F-FDG in oncology?[J]. J Nucl Med, 2021, 62(3): 296-302.   doi: 10.2967/jnumed.120.256271